Critical Care

official impact factor 4.60

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

Highly Access

Diagnosis and treatment of severe sepsis

Yann-Erick Claessens and Jean-François Dhainaut*

Critical Care 2007, 11(Suppl 5):S2 doi:10.1186/cc6153

Accesses  

  • Last 30 days: 296 accesses
  • Last 365 days: 4541 accesses
  • All time: 24159 accesses

Cited by

BioMed Central: 2 citations

Case report   Open Access Highly Accessed

Spot diagnosis: An ominous rash in a newborn

Kam-Lun Hon, King-Woon So, William Wong, Kam-Lau Cheung Italian Journal of Pediatrics 2009, 35:10 (30 April 2009)

Introduction   Free Highly Accessed

Introduction: severe sepsis and drotrecogin alfa (activated)

Antonio Artigas, Claude D Martin Critical Care 2007, 11(Suppl 5):S1 (19 December 2007)